1. Wegovy Fundamentals: The Gold Standard in GLP-1 Therapy
What is Wegovy?
Wegovy is the FDA-approved weight management formulation of semaglutide, the same active ingredient in Ozempic. It’s specifically dosed and packaged for chronic weight management in adults and adolescents (ages 12+).
Key Distinctions from Ozempic:
-
Higher maximum dose (2.4mg vs Ozempic’s 2mg)
-
Pre-filled single-dose pens (vs Ozempic’s multi-dose)
-
FDA-approved for obesity without diabetes requirement
Unprecedented Efficacy: Clinical Results
Trial | Population | Duration | Results |
---|---|---|---|
STEP 1 | BMI ≥30 | 68 weeks | 14.9% weight loss |
STEP 2 | BMI ≥27 + T2D | 68 weeks | 9.6% weight loss |
STEP 3 | BMI ≥30 | 68 weeks | 16% weight loss (with intensive lifestyle) |
STEP TEENS | Ages 12-17 | 68 weeks | 16.1% BMI reduction |
Real-World Data (2024):
-
83% achieve ≥10% weight loss
-
41% achieve ≥20% weight loss